bowel cancer
Folate intake and bowel cancer risk
6
. Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer.
36
Participation in bowel cancer screening: Examination of psychosocial processes
362
Familial Breast and Bowel Cancer: Does It Exist?
5
Hormone therapy in relation to survival from large bowel cancer.
18
Bowel cancer and previous mesh surgery
5
Outcomes of screening and surveillance in people with two parents affected by colorectal cancers: experiences from the Familial Bowel Cancer Service
9
Histopathology: improving outcomes in bowel cancer
18
Colorectal cancer screening in rural and remote areas: analysis of the National Bowel Cancer Screening Program data for South Australia
11
Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review
10
A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial
11
Perceived diagnostic delay and cancer related distress: a cross sectional study of patients with colorectal cancer
25
Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
15
Probiotics as a potential adjuvant therapy for the treatment of colorectal cancer
6
Understanding cancer of the colon and rectum (bowel)
45
Understanding cancer of the colon and rectum (bowel)
41
Tamoxifen for women at high risk of breast cancer
8
A Review on Extended Release Tablet of Lubiprostone for IBS-C
9
Mesenchymal stem cells in inflammatory bowel disease and cancer
251
Long-term outcome of rectal cancer treatment
177